Recordati Industria Chimica e Farmaceutica Logo

Recordati Industria Chimica e Farmaceutica

A global pharmaceutical group that researches, develops, and markets medicines.

REC | XMIL

Overview

Corporate Details

ISIN(s):
IT0003828271 (+4 more)
LEI:
815600FBF92FD3531704
Country:
Italy
Address:
VIA MATTEO CIVITALI, 1, 20148 MILANO

Description

Recordati Industria Chimica e Farmaceutica is a global pharmaceutical group engaged in the research, development, manufacturing, and commercialization of medicines and pharmaceutical chemicals. The company's operations are structured across three main areas: specialty and primary care, rare diseases, and consumer healthcare. It provides a range of prescription and self-medication treatments for both common and rare conditions, with a core therapeutic focus that includes cardiovascular diseases. The group develops and markets treatment options for a wide spectrum of health needs, serving patients in approximately 150 countries.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-28 16:06
Report of the Board of Statutory Auditors to the Shareholders’ Meeting
English 555.5 KB
2024-03-28 16:05
Relazione del Collegio Sindacale all’Assemblea degli Azionisti
Italian 1.5 MB
2024-03-25 18:05
RECORDATI: Update on the execution of the share buy-back program
English 447.5 KB
2024-03-25 18:04
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 439.1 KB
2024-03-22 19:43
RECORDATI: DOCUMENTS RELATING TO THE ORDINARY GENERAL MEETING OF THE SHAREHOLDE…
English 277.3 KB
2024-03-22 19:40
RECORDATI: DOCUMENTAZIONE RELATIVA ALL’ASSEMBLEA ORDINARIA DEL 22.04.2024
Italian 268.8 KB
2024-03-22 18:54
Directors' Report on item 3 on the agenda of the Ordinary Shareholders’ Meeting…
English 219.2 KB
2024-03-22 18:42
Relazione amministratori sul punto 3 all'OdG dell'Assemblea Ordinaria del 22.04…
Italian 228.8 KB
2024-03-22 18:38
Directors' Report on item 2 on the agenda of the Ordinary Shareholders’ Meeting…
English 2.8 MB
2024-03-22 18:34
Relazione amministratori sul punto 2 all'OdG dell'Assemblea Ordinaria del 22.04…
Italian 2.7 MB
2024-03-22 18:30
Report on the 2024 Remuneration Policy and remuneration paid for 2023
English 2.6 MB
2024-03-22 18:24
Relazione sulla Politica in materia di Remunerazione 2024 e sui compensi corris…
Italian 2.6 MB
2024-03-19 18:05
RECORDATI: Update on the execution of the share buy-back program
English 406.3 KB
2024-03-19 18:04
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 397.7 KB
2024-03-19 15:18
Call to an Ordinary General Meeting of the Shareholders 22.04.2024
English 139.6 KB

Automate Your Workflow. Get a real-time feed of all Recordati Industria Chimica e Farmaceutica filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Recordati Industria Chimica e Farmaceutica

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Recordati Industria Chimica e Farmaceutica via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.